The Safety of Natalizumab Administration in the Home During the COVID-19 Pandemic for Patients with Multiple Sclerosis
Rohae Musa, PharmD, Option Care Health; Maria Giannakos, PharmD, MBA, BCPS, BCSCP, Option Care Health; Suzanne Kluge, B.S. Pharm, MBA, RPh, BCSCP, FNHIA, Option Care Health
The study assessed the safety of natalizumab administration by comparing outcomes after receiving natalizumab infusions at home vs. infusion suites.